Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.7 |
mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |